In the 1980s, corporate takeover battles defined American business warfare. One Biglaw attorney engineered a defensive strategy that fundamentally altered how companies fought hostile acquisitions and shaped merger and acquisition law for decades.
The "poison pill," formally known as a shareholder rights plan, became the most effective weapon against unwanted takeovers. This defensive tactic allows a company's board to issue new shares at a steep discount if an outside party acquires a certain percentage of the company without board approval. The mechanism dilutes an acquirer's stake, making hostile bids prohibitively expensive and effectively poisoning the deal.
The strategy emerged during intensely competitive takeover activity in the 1980s. Investment banks and aggressive acquirers pursued targets with unprecedented aggression. Corporate boards needed legal defenses beyond simply refusing offers. The poison pill provided a mechanism that courts ultimately upheld as a legitimate exercise of board authority under Delaware corporate law, which governed most major corporations.
Delaware courts, particularly in cases addressing the legality of defensive tactics, established that boards could adopt poison pills if they acted in good faith and with reasonable investigation. This judicial deference gave poison pills powerful legal backing. Acquirers faced a choice: negotiate with the board or launch expensive proxy fights to replace directors and dismantle the defense.
The poison pill transformed corporate control. Rather than leaving companies defenseless against surprise bids, the tactic forced acquirers to negotiate. Boards gained leverage in determining sale prices and terms. The defensive strategy also created space for alternative bidders, potentially benefiting shareholders through auction processes.
Today, poison pills remain standard corporate governance tools, though they have evolved. Some shareholders now challenge their continued use, arguing they entrench management and discourage innovation. However, courts have largely upheld boards' authority to adopt these plans, recognizing their role in negotiating favorable terms.
The Biglaw attorney who pioneered